Growth potential UroDev Medical is a niche medical device maker focused on neurogenic bladder and chronic urinary retention, with a fundraising total of $13M and revenue under $1M, indicating a small but investable opportunity for early-stage partnerships, pilots, or distribution deals in urology.

Executive leadership Current leadership includes CEO Matt Monarski and a recently appointed board member Jayme Hanson, signaling an active governance framework and potential for strategic partnerships, channel development, and executive sponsorship for new product launches.

Geographic footprint Relocation and expansion to Edina, Minnesota, plus origins in California and Minneapolis headquarters, suggest Midwest access and distribution advantages for US hospital systems, clinics, and durable medical equipment channels.

Product focus The flagship product IntelliFlow targets chronic urinary retention, presenting a clear entry point for saltatory sales through urology clinics, home healthcare, and hospital procurement channels; opportunities exist for clinical validation, reimbursement discussions, and POD demonstration pilots.

Digital readiness Tech stack and online presence with Google Cloud and standard web tools indicate the company is computational-capable and open to digital marketing, data collection, and telemedicine-enabled service offerings; consider partnerships for clinical education, remote monitoring, or digital patient support.